SS
JAGX icon

SBI Securities’s Jaguar Health JAGX Stock Holding History

SBI Securities’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252 Buy
84
+11
+15% +$71 ﹤0.01% 3257
2026
Q1 		$953 Buy
73
+66
+943% +$1.45K ﹤0.01% 2673
2025
Q4 		$205 Hold
7
– – ﹤0.01% 3208
2025
Q3 		$513 Buy
7
+1
+17% +$68 ﹤0.01% 2948
2025
Q2 		$504 Buy
6
+5
+500% +$912 ﹤0.01% 2962
2025
Q1 		$95 Buy
+1
New +$565 ﹤0.01% 3457
2024
Q4 		– Hold
0
– – – 3445

Other funds holding JAGX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

SBI Securities's JAGX Position: Q2 2026 in Review

SBI Securities increased its Jaguar Health (JAGX) stake by 15% in Q2 2026, buying an estimated $71 and bringing the position to 84 shares worth $252. The position accounts for ﹤0.01% of the portfolio, ranked #3257.

SBI Securities first reported a position in JAGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $953 in Q1 2026. 8 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

  • SBI Securities held 84 shares of Jaguar Health worth $252 as of Q2 2026.
  • SBI Securities bought 11 Jaguar Health shares in Q2 2026, an estimated $71.
  • Jaguar Health made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3257 holding.
  • SBI Securities first reported a position in Jaguar Health in Q1 2025 and has held it in 6 quarters since.
  • SBI Securities's Jaguar Health position peaked at $953 in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.